JENIFER BRILLA: Open Payments
NPI 1902832082 · DUNMORE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$364 in 21 payments from 7 companies in 2025. Trend: 2023 $760 · 2024 $372 · 2025 $364
Food & beverage: $364
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 9 | $143 |
| Axsome Therapeutics, Inc. | 4 | $76 |
| Lundbeck LLC | 3 | $52 |
| Vanda Pharmaceuticals Inc. | 2 | $36 |
| Otsuka America Pharmaceutical, Inc. | 1 | $22 |
| Janssen Pharmaceuticals, Inc | 1 | $19 |
| Supernus Pharmaceuticals, Inc. | 1 | $15 |
Products named: INGREZZA, Auvelity, REXULTI, FANAPT, SPRAVATO, Qelbree.
Industry payments across PA — which companies pay providers there.
